Prudential Financial
CTIC

Prudential Financial’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Prudential Financial’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,415
Closed -$101K – 2765
2022
Q3 		$101K Buy
17,415
+5,300
+44% +$33K ﹤0.01% 2513
2022
Q2 		$72K Buy
+12,115
New +$62K ﹤0.01% 2547
2019
Q1 		– Sell
-15,686
Closed -$12K – 2521
2018
Q4 		$12K Buy
+15,686
New +$25.8K ﹤0.01% 2372
2016
Q2 		– Sell
-1,180
Closed -$6K – 2390
2016
Q1 		$6K Sell
1,180
-600
-34% -$4.79K ﹤0.01% 2292
2015
Q4 		$22K Buy
1,780
+240
+16% +$3.2K ﹤0.01% 2219
2015
Q3 		$22K Hold
1,540
– – ﹤0.01% 2206
2015
Q2 		$30K Buy
1,540
+50
+3% +$965 ﹤0.01% 2213
2015
Q1 		$27K Hold
1,490
– – ﹤0.01% 2216
2014
Q4 		$35K Buy
1,490
+485
+48% +$11.2K ﹤0.01% 2178
2014
Q3 		$24K Sell
1,005
-1,006
-50% -$26.2K ﹤0.01% 2199
2014
Q2 		$56K Buy
2,011
+1,006
+100% +$30.2K ﹤0.01% 2382
2014
Q1 		$34K Sell
1,005
-20
-2% -$683 ﹤0.01% 2247
2013
Q4 		$20K Buy
+1,025
New +$18.7K ﹤0.01% 2280

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Prudential Financial's CTIC Position: Q4 2022 in Review

Prudential Financial sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2022, closing a stake of 17,415 shares — an estimated $101K sold.

Prudential Financial first reported a position in CTIC in Q4 2013 and held it in 13 quarters. The position peaked at $101K in Q3 2022. 145 funds tracked by Wall St. Rank hold CTIC as of Q4 2022.

  • Prudential Financial reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 17,415 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2022, an estimated $101K.
  • Prudential Financial first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and held it in 13 quarters.
  • Prudential Financial's CTI BioPharma Corp. (DE) Common Stock position peaked at $101K in Q3 2022.
  • 145 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.